These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 22260120

  • 1. Characterization of ergocalciferol loaded solid lipid nanoparticles.
    Patel MR, San Martin-Gonzalez MF.
    J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA, Schicke BC, Paepenmüller T, Müller-Goymann CC.
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A, Singh S.
    Colloids Surf B Biointerfaces; 2011 Oct 15; 87(2):280-8. PubMed ID: 21689909
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K, Reddy H, Murthy RS.
    AAPS PharmSciTech; 2007 Oct 12; 8(4):E83. PubMed ID: 18181544
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH, Wu CT, Fang JY.
    Drug Dev Ind Pharm; 2010 Jul 12; 36(7):751-61. PubMed ID: 20136495
    [Abstract] [Full Text] [Related]

  • 13. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A.
    Adv Drug Deliv Rev; 2007 Jul 10; 59(6):411-8. PubMed ID: 17553589
    [Abstract] [Full Text] [Related]

  • 14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S, Ng WK, Tan RB.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):139-51. PubMed ID: 22664358
    [Abstract] [Full Text] [Related]

  • 15. The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN).
    Sznitowska M, Wolska E, Baranska H, Cal K, Pietkiewicz J.
    Eur J Pharm Biopharm; 2017 Jan 30; 110():24-30. PubMed ID: 27815177
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
    Akanda MH, Rai R, Slipper IJ, Chowdhry BZ, Lamprou D, Getti G, Douroumis D.
    Int J Pharm; 2015 Sep 30; 493(1-2):161-71. PubMed ID: 26200751
    [Abstract] [Full Text] [Related]

  • 18. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM.
    Int J Pharm; 2011 Mar 15; 406(1-2):163-72. PubMed ID: 21219990
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
    Corzo C, Meindl C, Lochmann D, Reyer S, Salar-Behzadi S.
    Eur J Pharm Biopharm; 2020 Jul 15; 152():44-55. PubMed ID: 32387704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.